SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    W. S. Oetting, D. P. Schladt, W. Guan, M. B. Miller, R. P. Remmel, C. Dorr, K. Sanghavi, R. B. Mannon, B. Herrera, A. J. Matas, D. R. Salomon, P.-Y. Kwok, B. J. Keating, A. K. Israni, P. A. Jacobson, Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles, American Journal of Transplantation, 2016, 16, 2
  2. 2
    Pooja Singh, Yue-Harn Ng, Mark Unruh, Kidney Transplantation Among the Elderly: Challenges and Opportunities to Improve Outcomes, Advances in Chronic Kidney Disease, 2016, 23, 1, 44

    CrossRef

  3. 3
    Felix Krenzien, Abdallah ElKhal, Markus Quante, Hector Rodriguez Cetina Biefer, Uehara Hirofumi, Steven Gabardi, Stefan G. Tullius, A Rationale for Age-Adapted Immunosuppression in Organ Transplantation, Transplantation, 2015, 1

    CrossRef

  4. 4
    Tammy Hod, Alexander S. Goldfarb-Rumyantzev, Clinical issues in renal transplantation in the elderly, Clinical Transplantation, 2015, 29, 2
  5. 5
    K Sanghavi, R C Brundage, M B Miller, D P Schladt, A K Israni, W Guan, W S Oetting, R B Mannon, R P Remmel, A J Matas, P A Jacobson, Genotype-guided tacrolimus dosing in African-American kidney transplant recipients, The Pharmacogenomics Journal, 2015,

    CrossRef

  6. 6
    Rebecca A Pulk, David S Schladt, William S Oetting, Weihua Guan, Ajay K Israni, Arthur J Matas, Rory P Remmel, Pamala A Jacobson, Multigene predictors of tacrolimus exposure in kidney transplant recipients, Pharmacogenomics, 2015, 16, 8, 841

    CrossRef

  7. 7
    Yun-Ying Shi, Dennis A. Hesselink, Teun van Gelder, Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipients, Transplantation Reviews, 2015, 29, 4, 224

    CrossRef

  8. 8
    Steven Gabardi, Stefan G. Tullius, Felix Krenzien, Understanding alterations in drug handling with aging, Current Opinion in Organ Transplantation, 2015, 20, 4, 424

    CrossRef

  9. 9
    Özlem Tapirdamaz, Dennis A. Hesselink, Samira el Bouazzaoui, Mohammad Azimpour, Bettina Hansen, Luc J.W. van der Laan, Wojciech G. Polak, Jaap Kwekkeboom, Ron H.N. van Schaik, Teun van Gelder, Herold J. Metselaar, Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation, Pharmacogenetics and Genomics, 2014, 24, 9, 427

    CrossRef

  10. 10
    Elisabet Størset, Nick Holford, Karsten Midtvedt, Sara Bremer, Stein Bergan, Anders Åsberg, Importance of hematocrit for a tacrolimus target concentration strategy, European Journal of Clinical Pharmacology, 2014, 70, 1, 65

    CrossRef

  11. 11
    Noël Knops, Elena Levtchenko, Bert van den Heuvel, Dirk Kuypers, From gut to kidney: Transporting and metabolizing calcineurin-inhibitors in solid organ transplantation, International Journal of Pharmaceutics, 2013, 452, 1-2, 14

    CrossRef

  12. 12
    Kristian Heldal, Karsten Midtvedt, Managing Transplant Rejection in the Elderly: The Benefits of Less Aggressive Immunosuppressive Regimens, Drugs & Aging, 2013, 30, 7, 459

    CrossRef

  13. 13
    Ken Ogasawara, Shripad D. Chitnis, Reginald Y. Gohh, Uwe Christians, Fatemeh Akhlaghi, Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients, Clinical Pharmacokinetics, 2013, 52, 9, 751

    CrossRef

  14. 14
    Douglas Scott Keith, Transplantation in the Elderly Patient, Clinics in Geriatric Medicine, 2013, 29, 3, 707

    CrossRef